Hospira Recalls Lactated Ringer's and 5% Dextrose Injection Bags
Hospira is recalling 275,448 bags of Lactated Ringer's and 5% Dextrose Injection due to potential punctures that may compromise sterility and cause leaks.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls involving significant injury or property damage reports, or structural defects in medical devices, are rated as Severe (4). The potential for sterility loss in IV fluids is a significant safety hazard.
Plain-English summary
Hospira, Inc. is recalling 275,448 bags of Lactated Ringer's and 5% Dextrose Injection, USP, 1000 mL containers. The affected products are prescription-only and were distributed nationwide, as well as in Puerto Rico and the U.S. Virgin Islands. The recall involves Lot # 34-134-JT and Lot # 34-166-JT, both with an expiration date of 10/15.
The recall was initiated due to a lack of assurance of sterility. The source text indicates a potential for punctures through the overwrap and primary container, which may result in IV bag leaks. This defect poses a risk to the sterility of the intravenous solution.
Healthcare providers and patients should stop using the affected lots immediately. Consumers should check their inventory for the specific lot numbers and expiration dates listed above and contact their healthcare provider or the manufacturer for further instructions.
The recalled product
- Product
- Lactated Ringer's and 5% Dextrose Injection, USP; 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7929-09.
- Manufacturer
- Hospira Inc.
- Category
- Drug — IV Fluids
- Affected units
- 275,448
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot # 34-134-JT Exp. 10/15 Lot # 34-166-JT Exp. 10/15
Distribution
Part of a larger recall action
This product is one of 11 recalled by Hospira Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 11 products in this recall →Related recalls
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · sterility loss
See all →- SevereChloraPrep One-Step Topical Solution Sterility Assurance Recall
FDA (Drugs) · 2026-07-01
- SevereNicardipine Hydrochloride Injection Recalled for Potential Sterility Loss
FDA (Drugs) · 2025-05-07
- HighSterile surgical drapes recalled due to potential packaging breach
FDA (Devices) · 2025-03-26
- HighMedline Proxima Sterile Surgical Drapes Recalled for Packaging Breach Risk
FDA (Devices) · 2025-03-26
- HighSurgical drapes recalled due to potential sterility breach in packaging
FDA (Devices) · 2025-03-26